235 related articles for article (PubMed ID: 27615517)
1. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses.
Fuchs S; Kaiser-Labusch P; Bank J; Ammann S; Kolb-Kokocinski A; Edelbusch C; Omran H; Ehl S
Eur J Immunol; 2016 Nov; 46(11):2639-2649. PubMed ID: 27615517
[TBL] [Abstract][Full Text] [Related]
2. Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome.
Kreins AY; Ciancanelli MJ; Okada S; Kong XF; Ramírez-Alejo N; Kilic SS; El Baghdadi J; Nonoyama S; Mahdaviani SA; Ailal F; Bousfiha A; Mansouri D; Nievas E; Ma CS; Rao G; Bernasconi A; Sun Kuehn H; Niemela J; Stoddard J; Deveau P; Cobat A; El Azbaoui S; Sabri A; Lim CK; Sundin M; Avery DT; Halwani R; Grant AV; Boisson B; Bogunovic D; Itan Y; Moncada-Velez M; Martinez-Barricarte R; Migaud M; Deswarte C; Alsina L; Kotlarz D; Klein C; Muller-Fleckenstein I; Fleckenstein B; Cormier-Daire V; Rose-John S; Picard C; Hammarstrom L; Puel A; Al-Muhsen S; Abel L; Chaussabel D; Rosenzweig SD; Minegishi Y; Tangye SG; Bustamante J; Casanova JL; Boisson-Dupuis S
J Exp Med; 2015 Sep; 212(10):1641-62. PubMed ID: 26304966
[TBL] [Abstract][Full Text] [Related]
3. Re-evaluation of IL-10 signaling reveals novel insights on the contribution of the intracellular domain of the IL-10R2 chain.
Wilbers RHP; van Raaij DR; Westerhof LB; Bakker J; Smant G; Schots A
PLoS One; 2017; 12(10):e0186317. PubMed ID: 29016674
[TBL] [Abstract][Full Text] [Related]
4. Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent.
Li Z; Gakovic M; Ragimbeau J; Eloranta ML; Rönnblom L; Michel F; Pellegrini S
J Immunol; 2013 Mar; 190(5):2335-44. PubMed ID: 23359498
[TBL] [Abstract][Full Text] [Related]
5. Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency.
Ogishi M; Arias AA; Yang R; Han JE; Zhang P; Rinchai D; Halpern J; Mulwa J; Keating N; Chrabieh M; Lainé C; Seeleuthner Y; Ramírez-Alejo N; Nekooie-Marnany N; Guennoun A; Muller-Fleckenstein I; Fleckenstein B; Kilic SS; Minegishi Y; Ehl S; Kaiser-Labusch P; Kendir-Demirkol Y; Rozenberg F; Errami A; Zhang SY; Zhang Q; Bohlen J; Philippot Q; Puel A; Jouanguy E; Pourmoghaddas Z; Bakhtiar S; Willasch AM; Horneff G; Llanora G; Shek LP; Chai LYA; Tay SH; Rahimi HH; Mahdaviani SA; Nepesov S; Bousfiha AA; Erdeniz EH; Karbuz A; Marr N; Navarrete C; Adeli M; Hammarstrom L; Abolhassani H; Parvaneh N; Al Muhsen S; Alosaimi MF; Alsohime F; Nourizadeh M; Moin M; Arnaout R; Alshareef S; El-Baghdadi J; Genel F; Sherkat R; Kiykim A; Yücel E; Keles S; Bustamante J; Abel L; Casanova JL; Boisson-Dupuis S
J Exp Med; 2022 Oct; 219(10):. PubMed ID: 36094518
[TBL] [Abstract][Full Text] [Related]
6. Selective Janus kinase inhibition preserves interferon-λ-mediated antiviral responses.
Schnepf D; Crotta S; Thamamongood T; Stanifer M; Polcik L; Ohnemus A; Vier J; Jakob C; Llorian M; Gad HH; Hartmann R; Strobl B; Kirschnek S; Boulant S; Schwemmle M; Wack A; Staeheli P
Sci Immunol; 2021 May; 6(59):. PubMed ID: 33990378
[TBL] [Abstract][Full Text] [Related]
7. Intestinal Epithelial Cell Tyrosine Kinase 2 Transduces IL-22 Signals To Protect from Acute Colitis.
Hainzl E; Stockinger S; Rauch I; Heider S; Berry D; Lassnig C; Schwab C; Rosebrock F; Milinovich G; Schlederer M; Wagner M; Schleper C; Loy A; Urich T; Kenner L; Han X; Decker T; Strobl B; Müller M
J Immunol; 2015 Nov; 195(10):5011-24. PubMed ID: 26432894
[TBL] [Abstract][Full Text] [Related]
8. Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance.
Simma O; Zebedin E; Neugebauer N; Schellack C; Pilz A; Chang-Rodriguez S; Lingnau K; Weisz E; Putz EM; Pickl WF; Felzmann T; Müller M; Decker T; Sexl V; Stoiber D
Cancer Res; 2009 Jan; 69(1):203-11. PubMed ID: 19118004
[TBL] [Abstract][Full Text] [Related]
9. Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice.
Shimoda K; Tsutsui H; Aoki K; Kato K; Matsuda T; Numata A; Takase K; Yamamoto T; Nukina H; Hoshino T; Asano Y; Gondo H; Okamura T; Okamura S; Nakayama K; Nakanishi K; Niho Y; Harada M
Blood; 2002 Mar; 99(6):2094-9. PubMed ID: 11877284
[TBL] [Abstract][Full Text] [Related]
10. Partial impairment of cytokine responses in Tyk2-deficient mice.
Karaghiosoff M; Neubauer H; Lassnig C; Kovarik P; Schindler H; Pircher H; McCoy B; Bogdan C; Decker T; Brem G; Pfeffer K; Müller M
Immunity; 2000 Oct; 13(4):549-60. PubMed ID: 11070173
[TBL] [Abstract][Full Text] [Related]
11. Control of Leishmania major in the absence of Tyk2 kinase.
Schleicher U; Mattner J; Blos M; Schindler H; Röllinghoff M; Karaghiosoff M; Müller M; Werner-Felmayer G; Bogdan C
Eur J Immunol; 2004 Feb; 34(2):519-29. PubMed ID: 14768057
[TBL] [Abstract][Full Text] [Related]
12. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.
Minegishi Y; Saito M; Morio T; Watanabe K; Agematsu K; Tsuchiya S; Takada H; Hara T; Kawamura N; Ariga T; Kaneko H; Kondo N; Tsuge I; Yachie A; Sakiyama Y; Iwata T; Bessho F; Ohishi T; Joh K; Imai K; Kogawa K; Shinohara M; Fujieda M; Wakiguchi H; Pasic S; Abinun M; Ochs HD; Renner ED; Jansson A; Belohradsky BH; Metin A; Shimizu N; Mizutani S; Miyawaki T; Nonoyama S; Karasuyama H
Immunity; 2006 Nov; 25(5):745-55. PubMed ID: 17088085
[TBL] [Abstract][Full Text] [Related]
13. Reduced interferon-gamma secretion by natural killer cells from rats susceptible to postviral chronic airway dysfunction.
Mikus LD; Rosenthal LA; Sorkness RL; Lemanske RF
Am J Respir Cell Mol Biol; 2001 Jan; 24(1):74-82. PubMed ID: 11152653
[TBL] [Abstract][Full Text] [Related]
14. Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation.
Shaw MH; Freeman GJ; Scott MF; Fox BA; Bzik DJ; Belkaid Y; Yap GS
J Immunol; 2006 Jun; 176(12):7263-71. PubMed ID: 16751369
[TBL] [Abstract][Full Text] [Related]
15. A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors.
Sohn SJ; Barrett K; Van Abbema A; Chang C; Kohli PB; Kanda H; Smith J; Lai Y; Zhou A; Zhang B; Yang W; Williams K; Macleod C; Hurley CA; Kulagowski JJ; Lewin-Koh N; Dengler HS; Johnson AR; Ghilardi N; Zak M; Liang J; Blair WS; Magnuson S; Wu LC
J Immunol; 2013 Sep; 191(5):2205-16. PubMed ID: 23894201
[TBL] [Abstract][Full Text] [Related]
16. Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia.
Nemoto M; Hattori H; Maeda N; Akita N; Muramatsu H; Moritani S; Kawasaki T; Maejima M; Ode H; Hachiya A; Sugiura W; Yokomaku Y; Horibe K; Iwatani Y
Sci Rep; 2018 May; 8(1):6956. PubMed ID: 29725107
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis.
Works MG; Yin F; Yin CC; Yiu Y; Shew K; Tran TT; Dunlap N; Lam J; Mitchell T; Reader J; Stein PL; D'Andrea A
J Immunol; 2014 Oct; 193(7):3278-87. PubMed ID: 25156366
[TBL] [Abstract][Full Text] [Related]
18. Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.
Piganis RA; De Weerd NA; Gould JA; Schindler CW; Mansell A; Nicholson SE; Hertzog PJ
J Biol Chem; 2011 Sep; 286(39):33811-8. PubMed ID: 21757742
[TBL] [Abstract][Full Text] [Related]
19. NK Cells Require Cell-Extrinsic and -Intrinsic TYK2 for Full Functionality in Tumor Surveillance and Antibacterial Immunity.
Simonović N; Witalisz-Siepracka A; Meissl K; Lassnig C; Reichart U; Kolbe T; Farlik M; Bock C; Sexl V; Müller M; Strobl B
J Immunol; 2019 Mar; 202(6):1724-1734. PubMed ID: 30718299
[TBL] [Abstract][Full Text] [Related]
20. Tyk2-signaling plays an important role in host defense against Escherichia coli through IL-23-induced IL-17 production by gammadelta T cells.
Nakamura R; Shibata K; Yamada H; Shimoda K; Nakayama K; Yoshikai Y
J Immunol; 2008 Aug; 181(3):2071-5. PubMed ID: 18641345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
